Poulvac Procerta HVT-ND

Authorised

This medicine is authorised for use in the European Union

Marek’s disease and Newcastle disease vaccine (live recombinant)

Overview

Up-to-date information on this veterinary medicinal product is available on the Veterinary Medicines Information website

Product details

• Name of medicine:
  Poulvac Procerta HVT-ND
• Active substance:
  turkey herpesvirus, strain HVT-ND (cell-associated), expressing the F protein gene of Newcastle disease virus, live
• International non-proprietary name (INN) or common name:
  Marek’s disease and Newcastle disease vaccine (live recombinant)

Pharmacotherapeutic group

• Immunologicals for aves
• Live viral vaccines
• Avian herpes virus (marek's disease)
• newcastle disease virus/paramyxovirus

Authorisation details

• EMA product number:
  EMEA/V/C/006679

Assessment history

Initial marketing authorisation documents

CVMP summary of positive opinion for Poulvac Procerta HVT-IBD-ND

Adopted Reference Number: EMA/CVMP/442900/2024